human induced pluripotent stem cell therapy (Evotec/Universitätsklinikum Hamburg-Eppendorf)

N/A

Report date: 2025/03/20 15:34:33

Base Information

Drug Namehuman induced pluripotent stem cell therapy (Evotec/Universitätsklinikum Hamburg-Eppendorf)
Drug Alias Nameheart failure therapy (Evotec/Medical Center Hamburg-Eppendorf)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesUniversitätsklinikum Hamburg-EppendorfEvotec SE
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A